126 These studies suggest that GLP-1R could be a potential target for creating new treatments for cerebral ischemic stroke and human neurodegenerative disorders
A recent review notes that lack of coverage and high out-of-pocket costs can lead to treatment interruptions or discontinuation, disproportionately affecting lower-income families ( 2 Discussion The evidence to date indicates that GLP-1 RAs have significant potential for treating adolescent obesity, but careful integration into clinical practice is essential
The therapeutic benefit which may accompany the higher doses should therefore be weighed against the possibility of a greater incidence of adverse effects
, Charlottesville, VA, weight loss patient
A controlled human study did not find a significant effect on stimulated ACTH or cortisol release
For patients who want a more direct approach, our medical team may recommend copper peptides by subcutaneous injection